References

Le L, Baer M, Briggs P Diagnostic accuracy of point-of-care fluorescence imaging for the detection of bacterial burden in wounds: results from the 350-patient fluorescence imaging assessment and guidance trial. Adv Wound Care (New Rochelle). 2021; 10:(3)123-136 https://doi.org/10.1089/wound.2020.1272

Serena TE, Gould L, Ousey K, Kirsner RS. Reliance on clinical signs and symptoms assessment leads to misuse of antimicrobials: post hoc analysis of 350 chronic wounds. Adv Wound Care (New Rochelle). 2021; https://doi.org/10.1089/wound.2021.0146

Serena TE, Harrell K, Serena L, Yaakov RA. Real-time bacterial fluorescence imaging accurately identifies wounds with moderate-to-heavy bacterial burden. J Wound Care. 2019; 28:(6)346-357 https://doi.org/10.12968/jowc.2019.28.6.346

Hartley P. Nature. 1952; 169:481-482 https://doi.org/10.1038/169481a0

Rutala WA, Cole EC, Thomann CA, Weber DJ. Stability and bactericidal activity of chlorine solutions. Infection Control and Epidemiology. 1998; 19:(5)323-327 https://doi.org/10.2307/30141372

Barsoumian A, Sanchez CJ, Mende K In vitro toxicity and activity of Dakin's solution, mafenide acetate, and amphotericin B on filamentous fungi and human cells. J Orthop Trauma. 2013; 27:(8)428-436 https://doi.org/10.1097/BOT.0b013e3182830bf9

Heggers JP, Sazy JA, Stenberg BD Bacterial and wound healing properties of sodium hypochlorite solutions: the 1991 Lindenberg Award. J Burn Care Rehabil. 1991; 12:(5)420-424 https://doi.org/10.1097/00004630-199109000-00005

Cotter JL, Fader RC, Lilley C, Herndon DN. Chemical parameters, antimicrobial activities, and tissue toxicity of 0.1 and 0.5% sodium hypochlorite solutions. Antimicrob Agents Chemother. 1985; 28:(1)118-122 https://doi.org/10.1128/AAC.28.1.118

Jones IA, Joshi LT. Biocide use in the antimicrobial era: a review. Molecules. 2021; 26:(8) https://doi.org/10.3390/molecules26082276

Lindfors J. A comparison of an antimicrobial wound cleanser to normal saline in reduction of bioburden and its effect on wound healing. Ostomy Wound Manage. 2004; 50:(8)28-41

Serena TE, Bowler PG, Schultz GS Are semiquantitative clinical cultures inadequate? Comparison to quantitative analysis of 1053 bacterial isolates from 350 wounds. Diagnostics. 2021; 11:(7) https://doi.org/10.3390/diagnostics11071239

Hiebert JM, Robson MC. The immediate and delayed post-debridement effects on tissue bacterial wound counts of hypochlorous acid versus saline irrigation in chronic wounds. Eplasty. 2016; 16

Serena T, Al-Jalodi O, Serena L Evaluation of the combination of a biofilm-disrupting agent and negative pressure wound therapy: a case series. J Wound Care. 2021; 30:(1)9-14 https://doi.org/10.12968/jowc.2021.30.1.9

Schwartz JA, Goss SG, Facchin F Surgical debridement alone does not adequately reduce planktonic bioburden in chronic lower extremity wounds. J Wound Care. 2014; 23:(9) https://doi.org/10.12968/jowc.2014.23.Sup9.S4

The efficacy of sodium hypochlorite antiseptic: a double-blind, randomised controlled pilot study

02 February 2022
7 min read
Volume 6 · Issue 1

Abstract

Objective:

According to a recent clinical trial, 82% of hard-to-heal wounds harbour levels of bacteria that impede healing. A follow-up analysis of trial data revealed that the use of antiseptic cleansers did not correlate with bacterial burden. At a minimum, these findings suggest the need for clinical research into the efficacy of antiseptics in reducing bacterial burden. Evidence supporting the bacterial killing ability of antiseptics is largely derived from preclinical and laboratory studies. Few clinical trials have examined bacterial levels and healing rates in hard-to-heal wounds. Fortunately, the advent of fluorescence imaging to detect bacterial burden has simplified the conduct of clinical research examining the effectiveness of antiseptics in the clinic setting. The aim of this study was to evaluate the efficacy of a modified sodium hypochlorite (NaOCl) solution in reducing wound size and bacterial load in hard-to-heal wounds.

Method:

In this randomised, double-blind pilot study, patients were randomised to one of two groups: daily wound cleansing with either normal saline solution (NSS) or NaOCl. Patients and investigators were blinded to the allocation. All wound types were included.

Results:

A total of 16 patients consented to participate. At the initial visit, the target ulcer was measured and a fluorescence image to evaluate bacterial load obtained. The wound was then cleansed with either NSS or NaOCl and fluorescence imaging repeated. Patients cleansed the wound daily in accordance with the randomisation schedule. They returned to the clinic weekly for four weeks, and on each visit the wound was measured and a fluorescence image captured. Patients receiving NaOCl had a greater percent reduction in wound area versus NSS; although the first phase of the study was not powered for statistical significance, there was a strong trend favouring NaOCl. In addition, there was greater bacterial reduction in the NaOCl group.

Conclusion:

Based on the results of this pilot study, enrolment has continued in order to increase the study's power. This pilot study suggests that sodium hypochlorite is efficacious in reducing bacterial burden and promoting healing.

Arecent clinical trial demonstrated that 82% of hard-to-heal wounds have bacterial levels that impede wound healing (>104 colony forming units (CFU)/g).1 Subsequent analysis of the trial data showed that the use of antiseptics does not correlate with bacterial burden at any level. The authors concluded that antiseptic use is haphazard at best.2 Clinicians across the US have embraced antiseptic cleansers in the treatment of hard-to-heal wounds. The evidence for cleansers is based on bacterial kill rates in laboratory studies and data from pre-clinical research. This new evidence highlights the need to study cleansers and topical antimicrobials in human clinical trials on hard-to-heal wounds.

In the past, conducting clinical trials on bacterial levels required biopsies for quantitative tissue culture. This invasive and expensive technique hindered research efforts. The advent of fluorescence imaging, that inexpensively detects bacterial burden in real-time, has simplified research on the efficacy of antiseptic agents. Fluorescence imaging (MolecuLight, US) is a validated technique that accurately identifies bacterial levels >104 CFU/g.1,3 Incorporating fluorescence imaging obviates the need for biopsies and the cost associated with quantitative analysis in many clinical trials.

Register now to continue reading

Thank you for visiting Wound Central and reading some of our peer-reviewed resources for wound care professionals. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Access to clinical or professional articles

  • New content and clinical updates each month